Nagano, Japan

Kousaku Ohkawa

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Shinshu University, Other. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kousaku Ohkawa. Retrieved from https://idiyas.com/inventor/kousaku-ohkawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:

goldMedal1 out of 128 
 
Shinshu University
 patents
silverMedal1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kousaku Ohkawa: Innovator in Liquid Embolic Agents

Introduction

Kousaku Ohkawa is a notable inventor based in Nagano, Japan. He has made significant contributions to the field of medical technology, particularly in the development of liquid embolic agents. His innovative work addresses critical challenges in treating vascular diseases.

Latest Patents

Ohkawa holds a patent for a liquid embolic agent composition. This composition is designed to overcome the limitations of conventional embolic agents used in treating vascular diseases, such as cerebral aneurysms. The patented composition includes a hydrogel forming component with calcium ion entrapping ability and an anti-biodegradation component. The hydrogel forming component consists of acidic polysaccharides like alginate, gellan gum, carrageenan, and carboxymethyl cellulose salt. The anti-biodegradation component includes substances such as hydroxypropyl methylcellulose, methylcellulose, polyvinyl alcohol, polyallylamine, poly-N-vinyl acetamide, and cellulose acetate.

Career Highlights

Throughout his career, Kousaku Ohkawa has worked at Shinshu University, where he has contributed to research and development in medical technologies. His work has been instrumental in advancing the understanding and application of liquid embolic agents in clinical settings.

Collaborations

Ohkawa has collaborated with notable colleagues, including Ichiro Yuki and Takaomi Nomura. These collaborations have further enriched his research and innovation efforts in the medical field.

Conclusion

Kousaku Ohkawa's contributions to the development of liquid embolic agents highlight his role as an innovator in medical technology. His patented work addresses significant medical challenges and showcases the potential for advancements in treating vascular diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…